Get the Stockscreener App
35.71
0.56%
0.20
After Hours:
36.40
0.69
+1.93%
Kiniksa Pharmaceuticals International Plc stock is traded at $35.71, with a volume of 328.23K.
It is up +0.56% in the last 24 hours and up +7.98% over the past month.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
See More
Previous Close:
$35.51
Open:
$35.53
24h Volume:
328.23K
Relative Volume:
0.44
Market Cap:
$1.55B
Revenue:
$384.10M
Net Income/Loss:
$-9.07M
P/E Ratio:
-255.07
EPS:
-0.14
Net Cash Flow:
$11.10M
1W Performance:
+6.63%
1M Performance:
+7.98%
6M Performance:
+66.95%
1Y Performance:
+40.76%
1-Day Range:
$35.12
$35.84
1-Week Range:
$33.45
$35.84
52-Week Range:
$17.82
$35.84
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile
Name
Kiniksa Pharmaceuticals International Plc
Sector
Phone
(781) 431-9100
Address
23 OLD BOND STREET, FLOOR 3, LONDON
Compare KNSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KNSA
Kiniksa Pharmaceuticals International Plc
|
35.71 | 2.63B | 384.10M | -9.07M | 11.10M | -0.14 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-13-25 | Initiated | Citigroup | Buy |
| Sep-13-24 | Initiated | Jefferies | Buy |
| May-03-24 | Initiated | Wells Fargo | Overweight |
| Jun-29-20 | Reiterated | BofA Securities | Buy |
| Apr-01-20 | Initiated | BofA/Merrill | Buy |
| Mar-11-19 | Initiated | Barclays | Overweight |
| Dec-12-18 | Reiterated | Wedbush | Outperform |
| Jun-19-18 | Initiated | JMP Securities | Mkt Outperform |
View All
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Latest News
Trexquant Investment LP Has $5.25 Million Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
PDT Partners LLC Trims Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Braidwell LP Decreases Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by American Century Companies Inc. - Defense World
Invesco Ltd. Has $744,000 Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CAO Michael Megna Sells 11,000 Shares - MarketBeat
Eben Tessari Sells 15,091 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Holdings Boosted by Wellington Management Group LLP - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 1-Year HighStill a Buy? - MarketBeat
Ieq Capital LLC Purchases New Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Hsbc Holdings PLC Cuts Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Charles Schwab Investment Management Inc. Has $3.65 Million Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kodai Capital Management LP Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
ADAR1 Capital Management LLC Has $920,000 Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Birchview Capital LP Takes Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Vestal Point Capital LP Takes $3.77 Million Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharma COO Tessari sells $535k in shares - Investing.com
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Kiniksa Pharmaceuticals shares rise 3.03% intraday after presenting at Citi's Biopharma and Back-to-school Conference. - AInvest
Walleye Capital LLC Invests $1.92 Million in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here - sharewise.com
Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here's Why - Yahoo Finance
Kiniksa Pharmaceuticals Highlights Cardiovascular Focus and Growth - TipRanks
Kiniksa Q4 rev. down 40% YoY, FY22 rev. down 49% YoY. - AInvest
Court Ruling & Tariff Uncertainty: Time to Bet on POST, TME & KNSA? - Nasdaq
Is This a Bottoming Phase for Kiniksa Pharmaceuticals Ltd. getLinesFromResByArray error: size == 0 - thegnnews.com
Applying sector rotation models to Kiniksa Pharmaceuticals Ltd.Weekly Trend Recap & Community Verified Swing Trade Signals - Newser
Russell Investments Group Ltd. Acquires 83,126 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals Ltd.’s volatility index tracking explained2025 Investor Takeaways & Smart Money Movement Tracker - Newser
Charles Schwab Investment Management Inc. Purchases 42,353 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Vanguard Group Inc. Grows Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Will Kiniksa Pharmaceuticals Ltd. stock go up soonQuarterly Profit Summary & High Accuracy Trade Signal Alerts - Newser
Analyzing drawdowns of Kiniksa Pharmaceuticals Ltd. with statistical toolsJuly 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
Visual analytics tools that track Kiniksa Pharmaceuticals Ltd. performanceJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Statistical indicators supporting Kiniksa Pharmaceuticals Ltd.’s strength2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - Newser
How to forecast Kiniksa Pharmaceuticals Ltd. trends using time seriesJuly 2025 PreEarnings & AI Enhanced Trading Alerts - Newser
Biotech Investor Focus: Kiniksa Pharmaceuticals Lines Up Key September Conference Appearances at Major Banks - Stock Titan
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences - GlobeNewswire
Is Kiniksa Pharmaceuticals Ltd. a candidate for recovery playMarket Volume Report & High Win Rate Trade Tips - Newser
Russell Investments Group Ltd. Has $1.88 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Fox Run Management L.L.C. Invests $252,000 in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Nuveen LLC Acquires Shares of 765,054 Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):